Amplifon SpAAMFPF 71 9-Day RSI is 11.88 as of Jun. 27, 2026. GuruFocus rates AMFPF with a GF Score™ of 71/100 and a GF Value™ of $31.18 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 125 Medical Distribution companies, Amplifon SpA ranks better than 68.8% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-27), Amplifon SpA's 9-Day RSI is 11.88.
The industry rank for Amplifon SpA's 9-Day RSI or its related term are showing as below:
AMFPF's 9-Day RSI is ranked better than 68.8% of 125
companies
in the Medical Distribution industry
Industry Median: 46.83
vs AMFPF: 11.88
Amplifon SpA (OTCPK:AMFPF) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Amplifon SpA 9-Day RSI Related Terms
AMFPF vs MCK, COR, CAH: 9-Day RSI Comparison
For the Medical Distribution subindustry, Amplifon SpA's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPF) has a 9-Day RSI of 11.88 as of Jun. 27, 2026. According to the industry distribution chart, Amplifon SpA ranks #39 out of 125 companies in the Medical Distribution industry, placing it in the top 31.2%.
Is Amplifon SpA's 9-Day RSI too high?
Amplifon SpA's current 9-Day RSI is 11.88. The Medical Distribution industry median 9-Day RSI is 46.83. Amplifon SpA's value of 11.88 is 74.6% below this industry median. Based on the distribution chart, Amplifon SpA ranks #39 out of 125 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's 9-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #39 out of 125 companies for 9-Day RSI. This puts Amplifon SpA in the upper half of its industry. The industry median 9-Day RSI is 46.83. Amplifon SpA's value of 11.88 is 74.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 46.83, based on 125 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current 9-Day RSI of 11.88 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 46.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current 9-Day RSI is 11.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $31.18, compared to a current price of $11.21 — trading 64% below its estimated fair value. The current 9-Day RSI is 11.88 and 74.6% below the Medical Distribution industry median of 46.83. Amplifon SpA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current 9-Day RSI is 11.88 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 64% below its estimated GF Value™ of $31.18.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
9-Day RSI: 11.88
GF Value™: $31.18 vs. price of $11.21 (64% below fair value)
Industry Position: 74.6% below the Medical Distribution median (#39 of 125)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
71GF Score
Get the complete analysis for AMFPF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 